HK1071757A1 - Imidazopyridines as cyclin dependent kinase inhibitors - Google Patents

Imidazopyridines as cyclin dependent kinase inhibitors

Info

Publication number
HK1071757A1
HK1071757A1 HK05104993A HK05104993A HK1071757A1 HK 1071757 A1 HK1071757 A1 HK 1071757A1 HK 05104993 A HK05104993 A HK 05104993A HK 05104993 A HK05104993 A HK 05104993A HK 1071757 A1 HK1071757 A1 HK 1071757A1
Authority
HK
Hong Kong
Prior art keywords
imidazopyridines
kinase inhibitors
dependent kinase
cyclin dependent
cyclin
Prior art date
Application number
HK05104993A
Other languages
English (en)
Inventor
Timothy J Guzi
Kamil Paruch
Ronald J Doll
Viyyoor M Girijavallabhan
Michael P Dwyer
Kartik M Keertikar
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of HK1071757A1 publication Critical patent/HK1071757A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK05104993A 2002-09-19 2005-06-15 Imidazopyridines as cyclin dependent kinase inhibitors HK1071757A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US41206302P 2002-09-19 2002-09-19
PCT/US2003/029498 WO2004026867A2 (fr) 2002-09-19 2003-09-17 Nouvelles imidazopyridines utilisees comme inhibiteurs des kinases dependantes des cyclines

Publications (1)

Publication Number Publication Date
HK1071757A1 true HK1071757A1 (en) 2005-07-29

Family

ID=32030794

Family Applications (1)

Application Number Title Priority Date Filing Date
HK05104993A HK1071757A1 (en) 2002-09-19 2005-06-15 Imidazopyridines as cyclin dependent kinase inhibitors

Country Status (19)

Country Link
US (2) US6992080B2 (fr)
EP (1) EP1539756B1 (fr)
JP (1) JP4845379B2 (fr)
KR (1) KR20050052500A (fr)
CN (1) CN100549011C (fr)
AR (1) AR041291A1 (fr)
AT (1) ATE378336T1 (fr)
AU (1) AU2003295332B2 (fr)
CA (1) CA2499639C (fr)
DE (1) DE60317529T2 (fr)
ES (1) ES2293068T3 (fr)
HK (1) HK1071757A1 (fr)
IL (1) IL167433A (fr)
MX (1) MXPA05003058A (fr)
MY (1) MY133311A (fr)
NZ (1) NZ538566A (fr)
TW (1) TWI351405B (fr)
WO (1) WO2004026867A2 (fr)
ZA (1) ZA200502278B (fr)

Families Citing this family (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69734362T2 (de) * 1996-12-03 2006-07-20 Sloan-Kettering Institute For Cancer Research Synthese von epothilonen, zwischenprodukte dazu, analoga und verwendungen davon
US20040037818A1 (en) * 1998-07-30 2004-02-26 Brand Stephen J. Treatment for diabetes
GB9819530D0 (en) 1998-09-09 1998-10-28 Smithkline Beecham Plc Novel compositions and use
US20020058286A1 (en) * 1999-02-24 2002-05-16 Danishefsky Samuel J. Synthesis of epothilones, intermediates thereto and analogues thereof
ES2204295B1 (es) * 2002-07-02 2005-08-01 Almirall Prodesfarma, S.A. Nuevos derivados de quinuclidina-amida.
DK1767535T3 (da) 2002-08-23 2010-04-12 Sloan Kettering Inst Cancer Syntese af epothiloner, mellemprodukter deraf, analoge og deres anvendelse
US7649006B2 (en) 2002-08-23 2010-01-19 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto and analogues thereof
WO2005012256A1 (fr) 2003-07-22 2005-02-10 Astex Therapeutics Limited Composes 1h-pyrazole 3,4-disubstitues et leur utilisation en tant que kinases dependant des cyclines (cdk) et modulateurs de la glycogene synthase kinase-3 (gsk-3)
GB0418328D0 (en) * 2004-08-17 2004-09-22 Imp College Innovations Ltd Cancer methods and medicaments
AR054425A1 (es) 2005-01-21 2007-06-27 Astex Therapeutics Ltd Sales de adicion de piperidin 4-il- amida de acido 4-(2,6-dicloro-benzoilamino) 1h-pirazol-3-carboxilico.
KR101345002B1 (ko) * 2005-01-21 2013-12-31 아스텍스 테라퓨틱스 리미티드 제약 화합물
WO2006077428A1 (fr) * 2005-01-21 2006-07-27 Astex Therapeutics Limited Composes pharmaceutiques
US8404718B2 (en) 2005-01-21 2013-03-26 Astex Therapeutics Limited Combinations of pyrazole kinase inhibitors
KR20070107707A (ko) * 2005-01-21 2007-11-07 아스텍스 테라퓨틱스 리미티드 피라졸 키나제 억제제와 추가 항종양제의 조합물
US20080255358A1 (en) * 2005-03-24 2008-10-16 Mark James Bamford Derivatives of Imidazo [1,2-A] Pyridine Useful as Medicaments For Treating Gastrointestinal Diseases
US7700773B2 (en) 2005-09-09 2010-04-20 Schering Corporation 4-cyano, 4-amino, and 4-aminomethyl derivatives of pyrazolo[1,5-a]pyridines, pyrazolo[1,5-c]pyrimidines and 2H-indazole compounds and 5-cyano, 5-amino, and 5-aminomethyl derivatives of imidazo[1,2-a]pyridines, and imidazo[1,5-a]pyrazines as cyclin dependent kinase inhibitors
US8546404B2 (en) 2005-12-13 2013-10-01 Merck Sharp & Dohme Compounds that are ERK inhibitors
US7807672B2 (en) 2006-02-16 2010-10-05 Schering Corporation Compounds that are ERK inhibitors
EP2026805A1 (fr) * 2006-05-08 2009-02-25 Astex Therapeutics Limited Combinaisons pharmaceutiques de dérivés de diazole pour le traitement du cancer
FR2906250B1 (fr) * 2006-09-22 2008-10-31 Sanofi Aventis Sa Derives de 2-aryl-6phenyl-imidazo(1,2-a) pyridines, leur preparation et leur application en therapeutique
US7951818B2 (en) 2006-12-01 2011-05-31 Galapagos Nv Imidazolopyridine compounds useful for the treatment of degenerative and inflammatory diseases
AU2007337886C1 (en) 2006-12-22 2014-10-16 Astex Therapeutics Limited Bicyclic heterocyclic compounds as FGFR inhibitors
PL2121687T3 (pl) 2006-12-22 2016-03-31 Astex Therapeutics Ltd Pochodne amin tricyklicznych jako inhibitory białkowej kinazy tyrozynowej
TWI428132B (zh) * 2007-07-02 2014-03-01 Lilly Co Eli 癌症化療效果之強化
GB0720041D0 (en) 2007-10-12 2007-11-21 Astex Therapeutics Ltd New Compounds
GB0720038D0 (en) 2007-10-12 2007-11-21 Astex Therapeutics Ltd New compounds
US8426441B2 (en) 2007-12-14 2013-04-23 Roche Palo Alto Llc Inhibitors of bruton's tyrosine kinase
JP5643105B2 (ja) * 2007-12-14 2014-12-17 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ 新規イミダゾ［１，２−ａ］ピリジン及びイミダゾ［１，２−ｂ］ピリダジン誘導体
RU2441004C1 (ru) * 2007-12-19 2012-01-27 Дженентек, Инк. 5-анилиноимидазопиридины и способы их применения
JP5496915B2 (ja) 2008-02-13 2014-05-21 シージーアイ ファーマシューティカルズ，インコーポレーテッド ６−アリール−イミダゾ［１，２−ａ］ピラジン誘導体、その製造方法、及びその使用方法
ES2556353T3 (es) 2008-02-21 2016-01-15 Merck Sharp & Dohme Corp. Compuestos que son inhibidores de las ERK
GB0810902D0 (en) 2008-06-13 2008-07-23 Astex Therapeutics Ltd New compounds
US8338604B2 (en) 2008-06-20 2012-12-25 Bristol-Myers Squibb Company Imidazopyridine and imidazopyrazine compounds useful as kinase inhibitors
CA2726460C (fr) 2008-07-15 2017-02-21 F. Hoffmann-La Roche Ag Nouvelles phenyl-imidazopyridines et pyridazines
EP2348018A4 (fr) * 2008-09-25 2012-04-25 Kyorin Seiyaku Kk Dérivé biarylique hétérocyclique et inhibiteur de pde le renfermant en tant qu'ingrédient actif
PT2373169E (pt) 2008-12-08 2015-10-05 Gilead Connecticut Inc Inibidores de imidazopirazina da syk
MX2011006094A (es) 2008-12-08 2011-11-29 Gilead Connecticut Inc Inhibidores de imidazopirazina syk.
GB0906472D0 (en) 2009-04-15 2009-05-20 Astex Therapeutics Ltd New compounds
GB0906470D0 (en) 2009-04-15 2009-05-20 Astex Therapeutics Ltd New compounds
US20120220581A1 (en) 2009-10-30 2012-08-30 Janssen-Cilag, S.A. IMIDAZO[1,2-b]PYRIDAZINE DERIVATIVES AND THEIR USE AS PDE10 INHIBITORS
AR080754A1 (es) 2010-03-09 2012-05-09 Janssen Pharmaceutica Nv Derivados de imidazo (1,2-a) pirazina y su uso como inhibidores de pde10
JP5938352B2 (ja) 2010-03-11 2016-06-22 ギリアード コネチカット， インコーポレイテッド イミダゾピリジンｓｙｋ阻害剤
EP2694500B1 (fr) * 2011-04-06 2015-05-27 Bayer Pharma Aktiengesellschaft IMIDAZONAPHTHYRIDINES SUBSTITUEES ET DE PRODUITS INTERMÉDIAIRES DE & xA; CELLE-CI
CA2838645C (fr) 2011-06-27 2020-03-10 Janssen Pharmaceutica Nv Derives de 1-aryl-4-methyl-[1,2,4]triazolo[4,3-a]quinoxaline
US8883819B2 (en) 2011-09-01 2014-11-11 Irm Llc Bicyclic heterocycle derivatives for the treatment of pulmonary arterial hypertension
US9669035B2 (en) 2012-06-26 2017-06-06 Janssen Pharmaceutica Nv Combinations comprising PDE 2 inhibitors such as 1-aryl-4-methyl-[1,2,4]triazolo-[4,3-A]]quinoxaline compounds and PDE 10 inhibitors for use in the treatment of neurological of metabolic disorders
ES2607184T3 (es) 2012-07-09 2017-03-29 Janssen Pharmaceutica, N.V. Inhibidores de la enzima fosfodiesterasa 10
US9073921B2 (en) 2013-03-01 2015-07-07 Novartis Ag Salt forms of bicyclic heterocyclic derivatives
PT3027618T (pt) 2013-07-30 2020-10-12 Kronos Bio Inc Polimorfo de inibidores de syk
AP2016009007A0 (en) 2013-07-30 2016-01-31 Gilead Connecticut Inc Formulation of syk inhibitors
WO2015084992A1 (fr) 2013-12-04 2015-06-11 Gilead Sciences, Inc. Procédés pour le traitement de cancers
TWI662037B (zh) 2013-12-23 2019-06-11 美商基利科學股份有限公司 脾酪胺酸激酶抑制劑
US9290505B2 (en) 2013-12-23 2016-03-22 Gilead Sciences, Inc. Substituted imidazo[1,2-a]pyrazines as Syk inhibitors
NZ726365A (en) 2014-07-14 2018-06-29 Gilead Sciences Inc Combinations for treating cancers
WO2017087409A1 (fr) 2015-11-18 2017-05-26 Genzyme Corporation Biomarqueur de maladie polykystique des reins et utilisations associées
BR112018014525A2 (pt) 2016-01-14 2018-12-11 Handok Inc compostos que antagonizam receptor de adenosina a3, método para preparação dos mesmos e aplicação médica dos mesmos
US11161843B2 (en) 2017-01-24 2021-11-02 Sumitomo Chemical Company, Limited Fused heterocyclic compound and composition containing same
CN110785419B (zh) * 2017-04-12 2024-03-01 博雅缉因（北京）生物科技有限公司 芳烃受体拮抗剂及其用途
CA3059939A1 (fr) * 2017-04-21 2018-10-25 Kyn Therapeutics Inhibiteurs d'indole ahr et leurs utilisations
CN115028640A (zh) 2017-08-25 2022-09-09 吉利德科学公司 Syk抑制剂的多晶型物
KR20210131372A (ko) 2019-02-22 2021-11-02 크로노스 바이오, 인코포레이티드 Syk 억제제로서의 축합된 피라진의 고체 형태
JP2023502531A (ja) 2019-11-26 2023-01-24 イケナ オンコロジー， インコーポレイテッド 多形カルバゾール誘導体およびその使用
WO2024068740A1 (fr) * 2022-09-28 2024-04-04 Origenis Gmbh Nouveaux inhibiteurs de cdk9

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5574042A (en) * 1992-11-02 1996-11-12 Fujisawa Pharmaceutical Co., Ltd Imidazo [1,2-a] pyridines and their pharmaceutical use
RU2128648C1 (ru) * 1993-09-10 1999-04-10 Эйсай Ко. Лтд. Производные сульфонамида, способы их получения, фармацевтическая композиция и способ лечения
AU5348396A (en) * 1995-05-01 1996-11-21 Fujisawa Pharmaceutical Co., Ltd. Imidazo 1,2-a pyridine and imidazo 1,2-a pyridezine derivati ves and their use as bone resorption inhibitors
SE9700661D0 (sv) 1997-02-25 1997-02-25 Astra Ab New compounds
SE9801526D0 (sv) 1998-04-29 1998-04-29 Astra Ab New compounds
SE9802794D0 (sv) * 1998-08-21 1998-08-21 Astra Ab New compounds
JP4007743B2 (ja) * 1999-02-26 2007-11-14 エーザイ・アール・アンド・ディー・マネジメント株式会社 血管新生阻害剤
JP4039856B2 (ja) * 2000-02-03 2008-01-30 エーザイ・アール・アンド・ディー・マネジメント株式会社 インテグリン発現阻害剤
SE0003186D0 (sv) 2000-09-07 2000-09-07 Astrazeneca Ab New process
EP1370261A2 (fr) * 2001-03-08 2003-12-17 AstraZeneca AB Utilisation nouvelle

Also Published As

Publication number Publication date
TW200407322A (en) 2004-05-16
KR20050052500A (ko) 2005-06-02
US7452902B2 (en) 2008-11-18
EP1539756B1 (fr) 2007-11-14
CN100549011C (zh) 2009-10-14
US20040097517A1 (en) 2004-05-20
ES2293068T3 (es) 2008-03-16
DE60317529T2 (de) 2008-09-25
ZA200502278B (en) 2006-05-31
MXPA05003058A (es) 2005-05-27
DE60317529D1 (de) 2007-12-27
US6992080B2 (en) 2006-01-31
ATE378336T1 (de) 2007-11-15
CA2499639A1 (fr) 2004-04-01
NZ538566A (en) 2008-02-29
AU2003295332B2 (en) 2007-01-18
EP1539756A2 (fr) 2005-06-15
WO2004026867A3 (fr) 2004-08-05
JP2006507254A (ja) 2006-03-02
TWI351405B (en) 2011-11-01
CA2499639C (fr) 2011-11-08
US20060030555A1 (en) 2006-02-09
WO2004026867A2 (fr) 2004-04-01
JP4845379B2 (ja) 2011-12-28
CN1703414A (zh) 2005-11-30
AU2003295332A1 (en) 2004-04-08
IL167433A (en) 2011-03-31
AR041291A1 (es) 2005-05-11
MY133311A (en) 2007-11-30

Similar Documents

Publication Publication Date Title
HK1071757A1 (en) Imidazopyridines as cyclin dependent kinase inhibitors
HK1071758A1 (en) Pyrazolopyridines as cyclin dependent kinase inhibitors
HK1071570A1 (en) Pyrazolopyrimidines as cyclin dependent kinase inhibitors
HK1071569A1 (en) Pyrazolopyrimidines as cyclin dependent kinase inhibitors
HK1072056A1 (en) Imidazopyrazines as cyclin dependent kinase inhibitors
AP2048A (en) Diazepinoindole derivatives as kinase inhibitors
IL173381A0 (en) 2-aminophenyl-4-phenylpyrimidines as kinase inhibitors
AU2003271566A8 (en) Pyrrolopyrazines as kinase inhibitors
IL165515A0 (en) Bisindolyl-maleimid derivatives as kinase inhibitors
PL375352A1 (en) Azaindole kinase inhibitors
IL172132A0 (en) Thienopyridone derivatives as kinase inhibitors
HK1071572A1 (en) PyrazoloÄ1,5-AÜpyrimidine compounds as cyclin dependent kinase inhibitors
PL373649A1 (en) Kinase inhibitors
ZA200606573B (en) Pyrazolopyrimidine-derivatives as cyclin dependent kinase inhibitors
IL176450A0 (en) Pyrrolotriazine compounds as kinase inhibitors
SI1569907T1 (sl) Na nikotinamidu osnovani kinazni inhibitorji
EP1543009A4 (fr) Composes de pyrrolotriazine inhibiteurs de kinase
AP2006003620A0 (en) Imidazopyrazine tyroshine kinase inhibitors
AU2003254053A8 (en) Pyrazolopyrimidines as protein kinase inhibitors
AU2003249442A1 (en) Kinase inhibitors
EP1558609A4 (fr) Inhibiteurs de kinase
AU2003254051A8 (en) Pyrazolopyrimidines as kinase inhibitors
AU2003261204A1 (en) Pyrazolopyrimidines as kinase inhibitors
PL378116A1 (pl) Heterocykliczne inhibitory kinazy
EP1569907A4 (fr) Inhibiteurs de kinase a base de nicotinamide

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20120917